HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms.

Autor: Yue L; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China.; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Sharma V; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Horvat NP; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Akuffo AA; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.; Cancer Biology PhD Program, University of South Florida, Tampa, FL., Beatty MS; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Murdun C; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.; Tissue Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Colin C; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Billington JMR; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.; Cancer Biology PhD Program, University of South Florida, Tampa, FL., Goodheart WE; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Sahakian E; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Zhang L; Department of Pathology, University of South Florida College of Medicine and Moffitt Cancer Center, Tampa, FL., Powers JJ; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Amin NE; Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Lambert-Showers QT; Tissue Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Darville LN; Proteomics Core, Moffitt Cancer Center, Tampa, FL., Pinilla-Ibarz J; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Reuther GW; Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Wright KL; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Conti C; Forma Therapeutics, Watertown, MA., Lee JY; Forma Therapeutics, Watertown, MA., Zheng X; Forma Therapeutics, Watertown, MA., Ng PY; Forma Therapeutics, Watertown, MA., Martin MW; Forma Therapeutics, Watertown, MA., Marshall CG; Forma Therapeutics, Watertown, MA., Koomen JM; Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Levine RL; Leukemia Center, Memorial Sloan Kettering Cancer Center, New York, NY., Verma A; Division of Hemato-Oncology, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY., Grimes HL; Division of Experimental Hematology and Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH., Sotomayor EM; Department of Hematology & Oncology, George Washington Cancer Center, Washington, DC; and., Shao Z; Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China., Epling-Burnette PK; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.; James A. Haley VA Hospital, Tampa, FL.

Publikováno v: Blood [Blood] 2020 Jan 16; Vol. 135 (3), pp. 191-207.